💨 Abstract

The University of Central Lancashire and Brinton Healthcare UK Ltd. have signed a MoU to collaborate on using nanoparticle technology to develop innovative treatments for skin diseases. The partnership will focus on using topical nanocarriers for targeted delivery and controlled release of active ingredients, aiming to treat chronic skin diseases like psoriasis and atopic dermatitis. The collaboration aims to enhance patient care, commercialization, and intellectual property opportunities.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖